pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension

Similar documents
Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

SUPPLEMENTAL MATERIAL

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

SUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

CVD Prevention, Who to Consider

Arterial function and longevity Focus on the aorta

Supplementary Online Content

SITA 100 mg (n = 378)

D Terentes-Printzios, C Vlachopoulos, G Vyssoulis, N Ioakeimidis, P Xaplanteris, K Aznaouridis, E Christoforatou, A Samentzas, A Siama, C Stefanadis

Supplementary Appendix

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation

Correlation of novel cardiac marker

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Real-world experience with riociguat in CTEPH

Coronary artery disease (CAD) risk factors

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Endothelial function is impaired in women who had pre-eclampsia

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Supplementary Online Content

Diagnosis is it really Heart Failure?

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Pulmonary Arterial Hypertension: Biomarkers and Treatment

Guidelines on cardiovascular risk assessment and management

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

SUPPLEMENTAL MATERIAL

Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction

Improving Diagnostic, Prognostic & Therapeutic Biomarkers in Heart Disease. Professor Mark Richards Medicine, University of Otago, Christchurch

Cardiovascular Diseases in CKD

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure

Shihui Fu 1,2, Yi Guo 2, Zhao Zhang 2, Leiming Luo 1* and Ping Ye 1*

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski


THE HEART OF THE MATTER MAYANNA LUND CMH

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

Table S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

Vitamin D supplementation of professionally active adults

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU

Weintraub, W et al NEJM March Khot, UN et al, JAMA 2003

Supplementary Online Content

HYPERTENSION AND OBESITY IN RELATION TO HIGH SENSITIVITY C-REACTIVE PROTEIN AND LIPID PROFILE IN IRAQI PATIENTS

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction

Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Arterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg

Combination therapy in the treatment of pulmonary arterial hypertension 2015 update

The role of physical activity in the prevention and management of hypertension and obesity

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Natriuretic Peptides The Cardiologists View. Christopher defilippi, MD University of Maryland Baltimore, MD, USA

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

ASSeSSing the risk of fatal cardiovascular disease

Know Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis

Copeptin in heart failure: Associations with clinical characteristics and prognosis

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

Obstructive sleep apnea syndrome (OSAS) is a common

egfr > 50 (n = 13,916)

Depok-Indonesia STEPS Survey 2003

Nitrate s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction (NEAT) A Randomized Clinical Trial

SMARTool clinical and biohumoral results. Chiara Caselli IFC-CNR

2017 Employee Wellness Health Assessment Report

Arterial Age and Shift Work

Risk Factors for Heart Disease

Individual Study Table Referring to Part of Dossier: Volume: Page:

Decreased Inflammatory Markers in Diabetic Patients with Angiographically Proved Coronary Artery Disease after 18 Months of Statins Therapy

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography

Form 8: Post Transplant Annual Followup

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Estrogens vs Testosterone for cardiovascular health and longevity

Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp

Review of guidelines for management of dyslipidemia in diabetic patients

Pulse wave velocity, augmentation index and arterial age in students

Biomarkers in risk prediction of heart and kidney disease

Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome

Oscar L. Lopez, M.D. Departments of Neurology and Psychiatry Alzheimer s Disease Research Center University of Pittsburgh School of Medicine

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Low HDL-levels: leave it or treat it?

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION

HEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida

Form 8: Post Transplant Annual Followup

Biomarkers and undiagnosed disease

The Framingham Coronary Heart Disease Risk Score

Transcription:

Supplementary material Jonas K, Magoń W, Waligóra M, et al. High density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension Pol Arch Intern Med. 2018. doi:10.20 452/pamw.4306 Please note that the journal is not responsible for the scientific accuracy or functionality of any supplementary material submitted by the authors. Any queries (except missing content) should be directed to the corresponding author of the article. Supplementary Methods Hypertension was diagnosed in patients with elevated systolic or diastolic blood pressure (BP) 140 or 90 mmhg, respectively or patients having been prescribed a BP-lowering drugs for high BP[1, 2]. Diabetes was diagnosed based on the plasma glucose criteria of the American Diabetes Association[3, 4], either the fasting plasma glucose or the 2-h plasma glucose value after a 75-g oral glucose tolerance test. Obesity was defined as BMI 30 kg/m2, and overweight as BMI 25 kg/m2 and < 30 kg/m2[5], [6], [7].

Supplementary Figure S1 Comparison of: 6MWD, HDL-C, hscrp and creatinine levels between long-term responders and female non-responders. Dots represent values of the parameters in long-term responders (vertical axis) and corresponding values in female non-responders (horizontal axis). The line represents hypothetical distribution of the parameters if no differences between subgroups are present. Abbreviations: 6MWD, six minute walk distance, m; HDL-C, high-density lipoprotein cholesterol, mg/dl; hscrp, high-sensitivity C-reactive protein, mg/l;

creatinine, μmol/l Supplementary Table S1 The area under curve (AUC) based variable importance scores based on the Conditional Random Forest approach. Mean 2.50% 97.50% Creatinine 0.35 0.27 0.43 CI 0.32 0.25 0.39 RA pressure 0.15 0.1 0.2 HDL-C 0.05 0.01 0.1 NT-proBNP 0.05 0.02 0.09 The mean and quantiles are based on 500 repetitions of the algorithm[8] The positive values indicate that the feature carries significant information about the predictor (as the AUC drops after removing this feature), whereas the negative values indicate the feature carries no more predictive power than an independent variable. Abbreviations: CI, cardiac index; HDL-C, high-density lipoprotein cholesterol; NT-proBNP, N-terminal pro-brain natriuretic peptide; RA, right atrium

Supplementary Table S2 The strength of association between the ΔmPAP and its most informative predictors as shown in the Lasso and Random Forest model. Coefficient Estimate P-value HDL-C 0.33 0.02 Creatinine -0.41 0.003 RA pressure -0.38 0.006 CI 0.4 0.003 Abbreviations: CI, cardiac index; HDL-C, high-density lipoprotein cholesterol; RA, right atrium Supplementary Table S3 Results (non-zero coefficients) of the LASSO-based variable selection for the binomial model with indicator of the event 'long-term response' as the dependent variable. Results are based on 8-fold cross-validation. Variable Coefficient 6-MWD 0.005 HDL-C 0.096 Hs-CRP -0.048 Creatinine -0.009

Abbreviations: 6-MWD, six minute walk distance; hscrp, high-sensitivity C-reactive protein; Il-1β, interleukin 1β; Il-6, interleukin 6; NT-proBNP, N-terminal pro-brain natriuretic peptide; PA, pulmonary artery; PVR, pulmonary vascular resistance; RA, right atrium; WHO-FC, WHO Functional Class Supplementary References 1. Kopec G, Podolec P, Podolec J, et al. Atherosclerosis progression affects the relationship between endothelial function and aortic stiffness. Atherosclerosis. 2009; 204: 250-254. 2. Czarnecka D, Jankowski P, Kopec G, et al. Polish Forum for Prevention Guidelines on Hypertension: update 2017. Kardiol Pol. 2017; 75: 282-285. 3. American Diabetes A. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2016; 39 Suppl 1: S13-22. 4. Malecki M, Kozek E, Zozulinska-Ziolkiewicz D, et al. Polish Forum for Prevention Guidelines on Diabetes: update 2017. Kardiol Pol. 2017; 75: 628-631. 5. Zahorska-Markiewicz B, Podolec P, Kopec G, et al. Polish Forum for Prevention Guidelines on overweight and obesity. Kardiol Pol. 2008; 66: 594-596. 6. Kopeć G, Moertl D, Jankowski P, et al. Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol. 2013; 29: 683-690. 7. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33: 1635-1701. 8. Janitza S, Strobl C, Boulesteix AL. An AUC-based permutation variable importance measure for random forests. BMC Bioinformatics. 2013; 14: 119.